Replay available

IMMUPHARMA PLC (IMM) — Investor Presentation

Investor Presentation hosted by IMMUPHARMA PLC (LSE: IMM) on Investor Meet Company, held 2022-08-04.

Thu, August 4, 2022 at 7:00 AMendedReplay
IMMUPHARMA PLC (IMM) — Investor Presentation

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Tim McCarthy

CEO at IMMUPHARMA PLC

Tim Franklin

COO at IMMUPHARMA PLC

Lisa Baderoon

IR at IMMUPHARMA PLC

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the IMMUPHARMA PLC Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged. They can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Just please simply type in your questions at any time and press send. The company may not be in a position to answer every question received during the meeting itself. However, the company review all questions submitted today and publish responses where it's appropriate to do so. Before we begin, we would like to submit the following poll. And if you'll give that your kind attention, I'm sure be most appreciated by the company. And I'd now like to hand over to chief operating officer Tim Franklin and chief executive officer Tim McCarthy. Good morning or good afternoon to you both. Good afternoon, Mark. Thank you very much for that introduction. Let me say good afternoon to all the listeners. Thank you very much for taking the time out to listen to the presentation today. As an introduction, I'm sure you're all aware that we put an r and s out yesterday concerning a fundraising which we're going through, and I'd I'd like to come back to that and maybe talk a little bit more about that at the end. But we thought we'd take the opportunity to make the presentation today, Tim and I, just to bring you up to speed with where we are with the company, what we see as a very exciting future going forward, and put the whole fundraising into context because we're clearly a period now, if you've read the RNS, where everyone has the opportunity to participate in the fundraising, which is something we we felt very strongly about giving people the opportunity to do. So having the back...

More from Immupharma Plc